BioAge Labs to Present at Upcoming Investor Conferences

Rhea-AI Summary

BioAge Labs (NASDAQ:BIOA) will participate in two upcoming investor conferences. Management will join fireside chats and one-on-one meetings at the Jefferies Global Healthcare Conference in New York on June 4, 2026, and the Goldman Sachs Global Healthcare Conference in Miami Beach on June 8, 2025.

Live webcasts will be accessible via registration links, with replays available for 30 days in the investor section of BioAge’s website.

News Market Reaction – BIOA

-0.78%

-0.78% Session close to close

In the May 22 session, BIOA declined 0.78%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EMERYVILLE, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will participate in the following upcoming investor conferences:

• Jefferies Global Healthcare Conference (New York, June 3–4, 2026): Dov Goldstein, MD, CFO, and BJ Sullivan, PhD, Chief Strategy Officer, are scheduled to participate in a fireside chat on Thursday, June 4 at 3:45–4:15 PM EDT, and will participate in one-on-one meetings. To access the live webcast of the presentation, register here.

• Goldman Sachs Global Healthcare Conference (Miami Beach, June 8–10, 2025): Dov Goldstein, MD, CFO, and BJ Sullivan, PhD, Chief Strategy Officer, are scheduled to participate in a fireside chat on Monday, June 8 at 2:40–3:15 PM EDT, and will participate in one-on-one meetings. To access the live webcast of the presentation, register here.

Replays of the webcasts will be available in the investor section of the Company's website at https://ir.bioagelabs.com/, and will be archived for 30 days following the presentations.

About BioAge Labs, Inc.

BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates for cardiometabolic diseases by targeting the biology of human aging. The Company's lead product candidate, BGE-102, is a potent, orally available, brain-penetrant small-molecule NLRP3 inhibitor being developed for cardiovascular risk and retinal diseases including diabetic macular edema. BGE-102 has completed a Phase 1 SAD/MAD trial demonstrating a well-tolerated profile and potential best-in-class reductions in hsCRP and other inflammatory biomarkers in participants with obesity and elevated inflammation. Phase 2 cardiovascular risk proof-of-concept data are anticipated by end of year 2026, and Phase 1b/2a diabetic macular edema proof-of-concept data are anticipated in mid-2027. The Company is also developing long-acting injectable and oral small molecule APJ agonists for obesity. BioAge’s additional preclinical programs, which leverage insights from the Company’s proprietary discovery platform built on human longevity data, address key pathways involved in metabolic aging.

Contacts
PR: Chris Patil, media@bioagelabs.com
IR: Dov Goldstein, ir@bioagelabs.com
Partnering: partnering@bioagelabs.com
Web: https://bioagelabs.com

FAQ

When will BioAge Labs (NASDAQ:BIOA) present at the Jefferies Global Healthcare Conference 2026?

BioAge Labs will join a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 4, 2026, from 3:45–4:15 PM EDT. According to BioAge, executives will also participate in one-on-one investor meetings during the June 3–4, 2026 event in New York.

What is BioAge Labs presenting at the Goldman Sachs Global Healthcare Conference 2025?

BioAge Labs plans a fireside chat at the Goldman Sachs Global Healthcare Conference on Monday, June 8, 2025, from 2:40–3:15 PM EDT. According to BioAge, CFO Dov Goldstein and Chief Strategy Officer BJ Sullivan will also hold one-on-one meetings with investors in Miami Beach.

How can investors access the BioAge Labs (BIOA) webcasts for the June 2025 and 2026 conferences?

Investors can access live webcasts of BioAge Labs’ fireside chats by registering through the provided webcast links. According to BioAge, replay recordings will be posted in the investor section of its website and kept available for 30 days after each presentation.

Which BioAge Labs executives will speak at the Jefferies and Goldman Sachs healthcare conferences?

BioAge Labs will be represented by CFO Dov Goldstein, MD, and Chief Strategy Officer BJ Sullivan, PhD, at both conferences. According to BioAge, they will participate in scheduled fireside chats and conduct one-on-one meetings with institutional investors during the events.

Where will replays of BioAge Labs’ June 2025 and 2026 investor conference presentations be available?

Replays of BioAge Labs’ conference webcasts will be available in the investor section of its website at https://ir.bioagelabs.com/. According to BioAge, each replay will remain archived and accessible to investors for 30 days following the respective presentations.